Showing results (41-50 of 397) with videos related to
Sort By:
Pageof 40
International Journal of Molecular Sciences|June 10, 2023
Lights and Shadows of Sepsis Management: Challenges and Future PerspectivesAlessandro Russo, Rita Pallone, Enrico Maria Trecarichi, et al.Cancers|October 23, 2021
Neuregulin 1 Gene (NRG1). A Potentially New Targetable Alteration for the Treatment of Lung CancerDaniel Rosas, Luis E Raez, Alessandro Russo, et al.Infectious Disease Reports|October 27, 2015
Spontaneous Bacterial Peritonitis Due to Methicillin-Resistant Staphylococcus Aureus in a Patient with Cirrhosis: The Potential Role for Daptomycin and Review of the LiteratureMarco Falcone, Alessandro Russo, Giovanni Pacini, et al.Nanomaterials (Basel, Switzerland)|March 21, 2020
Renewable Fabric Surface-Initiated ATRP Polymerizations: Towards Mixed Polymer BrushesWojciech Raj, Alessandro Russo, Yaoming Zhang, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 8, 2023
Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresisAntonio Lacquaniti, Susanna Campo, Alessandro Russo, et al.Critical Reviews in Oncology/Hematology|August 7, 2024
Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targetingSruthi Ranganathan, Aswanth Reddy, Alessandro Russo, et al.Joints|December 1, 2016
Posterior tibial tendon displacement behind the tibia and its interposition in an irreducible isolated ankle dislocation: a case report and literature reviewAlessandro Ortolani, Roberto Bevoni, Alessandro Russo, et al.International Journal of Molecular Sciences|October 14, 2022
Time to Effective Therapy Is an Important Determinant of Survival in Bloodstream Infections Caused by Vancomycin-Resistant Enterococcus sppAlessandro Russo, Alice Picciarella, Roberta Russo, et al.Future Oncology (London, England)|July 11, 2018
Acquired resistance in oncogene-addicted non-small-cell lung cancerClaudio Sini, Alessandro Tuzi, Giovanni Rossi, et al.Clinical Drug Investigation|September 18, 2025
Cost-Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small-Cell Lung Cancer in ItalyAndrea Marcellusi, Marco Belfiore, Rosaria Tempre, et al.Pageof 40